Dinosynth Biotechnology has landed a contract to manufacture antibodies for ImmunoGen.
Terms of the deal were not disclosed.
Dinosynth will manufacture the huN901-DM1 anticancer compound for ImmunoGen, which is based in Cambridge, MA.
Diosynth: www.dinosynthbiotechnology.com
